A new device for beating heart bipolar radiofrequency atrial ablation  by Bonanomi, Gianluca et al.
A new device for beating heart bipolar radiofrequency
atrial ablation
Gianluca Bonanomi, MDa
David Schwartzman, MDb
David Francischelli, MSc
Kim Hebsgaard, MDa
Marco A. Zenati, MDa,b
Objective: A technique for mimicking left atrial atriotomies using an ablation device
that can be deployed without cardiopulmonary bypass has been developed.
Methods: In 12 healthy large (35-50 kg) adult pigs, maze-like ablation lesions were
directly applied to the left atrial epicardium on the beating heart. The ablation device
is irrigated, with a bipolar “hemostat” morphology, utilizing radiofrequency energy.
Prior to and after ablation, left atrial electromechanical properties were measured
during sinus rhythm in the latest 5 pigs using percutaneous endocardial catheter
electromechanical mapping and intracardiac echocardiography. Pathologic analysis
was performed acutely.
Results: All ablation lesions demonstrated conduction block along their entire
course. Global left atrial conduction time (49.4 8.8 milliseconds before vs 58.8
9 milliseconds after) and pattern were not significantly altered. Although a signif-
icant amount (17.12%  9%) of myocardium was either ablated or electrically
isolated, ablation was not associated with significant alterations in global left atrial
mechanics (left atrium ejection fraction 19% before vs 17% after; pulmonary vein
peak flow velocity 1.22 m/s before vs 1.38 m/s after; peak mitral inflow velocity
2.34 m/s before vs 2.64 m/s after), mitral valve function, nor left ventricular
function. There was no evidence of atrial thrombus formation. Transmurality was
achieved in most lesions with no evidence of charring or barotrauma.
Conclusions: Utilizing this ablation device, atrial lesions similar to the left compo-
nent of the Maze procedure were deployed with uniform success in a beating heart
without cardiopulmonary bypass or atriotomy and without adverse effects on left
atrial electromechanics.
The surgical approach to atrial fibrillation (AF) is evolving since theintroduction of the maze procedure by Cox and associates.1 Lessextensive atrial incisions, replacement of the cut and sew lesionswith cryoablation, and microwave or radiofrequency (RF) energyapplication and beating heart approaches have already been de-scribed although further studies are needed to confirm their safety
and efficacy.2-5 A new device has been developed to create surgical ablation of the
atrium from the epicardial surface of the heart using RF energy. The ablation device
features a “hemostat” morphology able to deliver bipolar RF energy and is irrigated.
The purpose of this study was to investigate the feasibility, safety, and reproduc-
ibility of an anatomy-based ablation of the left atrium (LA) that was performed on
the epicardial surface of the beating heart in a healthy swine model. Moreover, an
electromechanical assessment of the LA was performed prior to and after ablation
using percutaneous endocardial catheter mapping and intracardiac echocardiogra-
phy. Such a procedure delivered without cardiopulmonary bypass (CPB) would, if
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uniformly safe and if similar outcomes to the maze proce-
dure are realized, become applicable to a broad population
of patients with or at risk for AF who are undergoing
cardiac surgery and for a smaller population as the lone
indication for surgery.
Materials and Methods
Animals
Twelve healthy Hanford swine of either sex were used in this
study. The mean weight was 40.4  5.6 kg. All animals received
humane care in a facility fully accredited by the Council on
Accreditation of the Association for Assessment and Accreditation
of Laboratory Animal Care, in accordance with the Guide for the
Care and Use of Laboratory Animals published by the National
Institute of Health (NIH publication no. 85-23, revised 1985). The
study protocol was approved by the Institutional Animal Care and
Use Committee of the University of Pittsburgh.
Anesthesia
Animals were premedicated with intramuscular ketamine (20 mg/
kg) and isoflurane (1%-2%) delivered by face mask prior to
endotracheal intubation. Anesthesia was maintained with isoflu-
rane mixed with low flow oxygen and room air. Vascular access
was obtained by surgical cut-down of the right carotid artery for
blood pressure monitoring and the right jugular vein for fluid
administration. Mean arterial blood pressure was kept stable
around 75 mm Hg. At the completion of the experiments, the
animals were put to death using a lethal injection of potassium
chloride while under anesthesia.
Radiofrequency Ablation
RF energy was delivered to the heart using the prototype of a new
ablation device manufactured by Medtronic Inc. The system was
designed to ablate tissue by the induction of thermal necrosis in the
targeted tissues. The surgical hand piece incorporates 2 electrodes
on separate arms of a hemostat instrument able to deliver bipolar
RF energy (Figure 1). Each electrode features a platinum/iridium
conductor, a porous polymer, and saline irrigation (250 mL/h).
Power (35 watts) was delivered from a Cardioblate Generator
(Medtronic, Inc) connected to a custom LabView (National Instru-
ments, Austin, Tex) software that monitors tissue impedance, in
real time, every 200 milliseconds as a measure of lesion transmu-
rality. The temperature was not measured at the probe, and the
saline irrigation for cooling of the electrode-tissue interface al-
lowed us to delay the production of microbubbles and a sudden
rise in impedance that could prevent the device from applying
sufficient energy to the tissue.
Surgical Procedure
The heart was exposed through a median sternotomy and a beating
heart procedure in which the RF energy was applied to the LA
from the epicardial surface was performed. The Starfish
(Medtronic Inc) heart positioning system was applied to the apex
of the left ventricle and the heart lifted to expose the posterior wall
of the LA. The left and right pulmonary veins (LPV and RPV) as
well as the inferior vena cava were surgically isolated to enable the
placement of the ablation device. A long right-angle tool was used
to dissect the common trunk of the LPV in proximity of the LA
wall. Likewise, the common trunk of the RPV was isolated at the
junction with the LA by entering and dissecting the Waterston
groove. A modification of the left-sided maze was delivered with
the RF device as illustrated in Figure 2. The procedure included
lesions to isolate the LPV, the RPV, and the left atrial appendage
(LAA) as well as connecting lesions between the two pulmonary
veins and between the LPV and the LAA. The connecting lesion
between the LPV and the RPV was performed on the inferior
aspect of the LA. In preliminary experiments, access to the roof of
the LA to deliver a superior connecting lesion between the LPV
and the RPV was attempted but the technique proved to be more
demanding and resulted in poor transmurality.
Lesion Assessment
The real-time assessment of lesion creation was performed by
monitoring the decrease in impedance with respect to time. The
transmurality algorithm did not operate on absolute impedance
readings but rather on relative changes in tissue impedance during
the ablation cycle. Heating tissue caused denaturation of the so-
dium potassium pumps within the cell wall, leading to a decrease
in tissue impedance. By continually calculating the change in
Figure 1. The ablation device featuring the bipolar delivery of RF
energy and saline irrigation on each arm of a clamping instru-
ment.
Figure 2. Epicardial atrial ablation pattern. LAA, Left atrial ap-
pendage; LA, left atrium; RA, right atrium; LPV, left pulmonary
vein; RPV, right pulmonary vein; IVC, inferior vena cava; dotted
lines, ablation lesions.
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impedance the tissue was ablated until there was a plateau in the
impedance that was considered as the point of transmurality.
Therefore, this algorithm was independent of tissue type or loca-
tion. Following the lesion creation, the assessment of the efficacy
of ablation to produce conduction block was accomplished through
an attempt to pace across each lesion. Conduction block was
considered as the inability to capture the atrium at 15 mA.
Intracardiac Echocardiography
Vascular access was achieved via percutaneous right and left
femoral venipuncture using the Seldinger technique. The Acunav
intracardiac echocardiography catheter (Acuson Inc, Mountain
View, Calif) was advanced into the right atrium for high-quality
imaging of both atria, including B-mode imaging as well as pulsed,
continuous wave and color Doppler at 7.5 or 8.5 MHz.6 A quali-
tative and quantitative evaluation of the heart was performed just
prior to and 60 minutes after atrial ablation in 5 pigs. The heart was
examined for any evidence of thrombus formation and wall motion
abnormality (WMA). RPV and LPV diameter and flow as well as
peak transmitral valve inflow (TMV) and left ventricle ejection
fraction (LVEF) were assessed. For pulmonary vein flow the peak
systolic (P1), diastolic (P2), and retrograde (A) waves were mea-
sured as previously described.7
Electromechanical Mapping
Following intracardiac echocardiography, an electromechanical
study was performed before and after epicardial atrial ablation in
5 pigs. A mapping system (NOGA; Biosense/Webster, Diamond
Bar, Calif) utilizing synchronous extracorporeal magnetic fields to
determine the location and orientation of a sensor mounted within
a 7F intracardiac catheter (Navi-Star; Biosense Webster, Diamond
Bar, Calif) provided detailed activation maps as well as local
electrocardiogram data.8 A reference catheter was placed on the
animal’s back. The LA was entered via atrial transseptal puncture
to enable the advancement of the mapping catheter. The method
samples the location of the intracardiac catheter throughout the
cardiac cycle at different endocardial sites and reconstructs a
dynamic tridimensional (3D) electromechanical map of the LA.
Local activation time and unipolar and bipolar electrical potentials
are acquired simultaneously, color-coded, and represented on the
3D anatomical map. From the electromechanical information dur-
ing systole and diastole the system can provide global and regional
functional data including the LA end-diastolic and end-systolic
volumes (LA ED and LA ES), the LA ejection fraction (LA EF),
the electrical activation time (AT) and bipolar endocardial electri-
cal signals.
Postmortem Analysis
After each pig was killed, the chest was carefully inspected to
exclude any damage to cardiac and mediastinal structures; the
heart was excised and analyzed macroscopically for any evidence
of trauma or thrombus formation in the LA. The specimen was
stained with 1% triphenyltetrazolium chloride (TTC) and cross
sections encompassing the lesions were analyzed for dimensions
and transmurality.
Statistical Analysis
Results are reported as mean and standard deviation values. For the
comparison of preablation and postablation variables a paired
Student t test was used. A P value  .05 was considered signifi-
cant.
Results
Surgical Ablation
The hand piece design enabled the delivery of the encircling
lesions around the LPV and the RPV following minimal
surgical dissection (Figure 3). The LAA lesion was deliv-
ered by clamping the finger-shaped appendage at its base.
The hemostat design was suitable for delivering the inter-
Figure 3. The left pulmonary vein is isolated following minimal surgical dissection and the RF energy delivered
using the bipolar device.
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connecting lesions by grasping and pinching the targeted myo-
cardial tissue with the jaws of the bipolar device. Two pinch-
ings were needed to complete the full interconnecting lesion
between the RPV and the LPV as well as between the LPV and
the LAA. The time required for delivering each lesion ranged
from 7 to 55 seconds (Table 1). The total procedure time was
14  6 minutes. No complications were observed.
Pacing Results
Pacing thresholds before ablation were less than 1 mA.
Conduction could be assessed for RPV, LPV, and LAA
lesions. A significant increase of the pacing threshold to
supraphysiologic values was observed in all cases. The
threshold was increased to more than 20 mA for all lesions
except for 2 cases in which the atrium was captured at 15
mA from the isolated LAA (Table 1). Although the device
indicated an impedance leveling and the lesions appeared
transmural on postmortem analysis, the presence of micro
gaps of nontransmurality in the thick and trabeculated LAA
cannot be excluded and might explain the lower pacing
threshold. Moreover, the TTC staining that was adopted
does have limitations in the evaluation of postmortem trans-
murality as demonstrated in previous studies.9
Postmortem Analysis
No damage to surrounding structures in the mediastinum
was observed. Gross examination of the LA and pulmonary
veins revealed no evidence of tearing, barotrauma, or
thrombus formation. Lesion analysis after TTC staining
showed uniform transmural lesions in most instances (Table
1). LPV, RPV, and LAA lesions were transmural along their
entire course in all cases (Figure 4). Transmurality was not
complete along the entire course of the ablating lesion in 1
LAA-LPV and in 2 LPV-RPV interconnecting lesions.
However, it should be pointed out that the entire lesion was
categorized as nontransmural whenever any gap not com-
pletely transmural was found. The transmurality gaps were
documented at the junction of the interconnecting lesion
with either the LPV or the RPV lesion and were probably of
technical nature, due to variable amounts of myocardial
tissue that was actually pinched into the jaws of the device.
As a matter of fact, access to the relevant areas and the
positioning of the device was sometimes difficult and might
have impaired the achievement of transmurality. We believe
that technical limitations prevented us from getting a proper
bite of tissue when the pinch technique was adopted. The
problem might be surmountable by applying additional le-
sions or by increasing the amount of RF power to perform
the interconnecting lesions. The width of ablating lesions
ranged from 1 to 5 mm and tended to be larger on thick and
trabeculated atrial tissue (ie, LAA) (Table 1).
Intracardiac Echocardiography
In each pig, the Acunav catheter was advanced via the right
femoral vein into the RA using tip deflectability without
fluoroscopic guidance. LA structures and pulmonary ven-
tricle imaging were obtained as well as left ventricle long-
axis and short-axis views.
Indexes of global LA and left ventricular systolic func-
tion, such as TMV and LVEF, were not affected signifi-
cantly by LA ablation. No significant changes were ob-
served in LPV and RPV diameter and flow, although the
absence of acute pulmonary vein stenosis or blood flow
acceleration does not exclude the development of a stenosis
in the longer term. Moreover, no WMA or thrombus for-
mation was detectable acutely after ablation. Echocardio-
graphic data are summarized in Table 2.
Electromechanical Mapping
High-density maps counting an average of 200 sampled
points were recorded. Unipolar and bipolar endocardial
potentials were recorded by the catheter electrode and were
converted into 3D electrical maps where the voltage value
was displayed on a graded color scale (Figure 5). Endocar-
dial zones with low electrical activity (ie, bipolar voltage 
1 mV) were assumed to be representative of abnormal
electromechanical activity. A distinct ablation pattern was
reproduced by the electrical maps as demonstrated in Figure
5. The earliest electrical activation was detected on the
medial aspect of the LA in the region of the Bachmann
bundle and spread to the lateral and inferior aspects of the
atrial chamber. The global LA AT was 49.4  8.8 milli-
seconds prior to ablation. Postablation, the electrical acti-
vation pattern was similar to preablation (ie, starting in the
TABLE 1. Ablation lesion features
Lesion
Energy
(watts)
Ablation time
(seconds)
Threshold
(mA)
Transmurality
(% cases; n)
Width
(mm)
LAA 35 30 7 20 (15 in 2 cases) 100%; 12 3 0.5
LPV 35 20 5 20 100%; 12 2 0.5
RPV 35 10 2 20 100%; 12 3 0.2
LAA-LPV 35 20 5 ND 91%; 11 2 1
LPV-RPV 35 40 10 ND 83%; 10 2.5 0.8
LAA, Left atrial appendage; LPV, left pulmonary vein; RPV, right pulmonary vein; ND, not determined.
Data are mean  SD; n  12.
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Bachmann bundle region and spreading to the lateral and
inferior LA) and the global LA AT was not significantly
altered (59  9 milliseconds, P  .18). Although a large
volume of LA myocardium was either ablated or electrically
isolated (ie, endocardial points with bipolar voltage 1 mV
increased from 12.38%  9% to 29.5%  9.4%, P  .01),
the ablation procedure was not associated with significant
alterations in global LA mechanics (Table 3).
Discussion
The gold standard for the surgical treatment of AF is the
maze III procedure developed by Cox and associates,10 in
which multiple atrial incisions are made to direct the sinus
impulse through a path or a maze to reach the atrioventric-
ular node. Although the results reported by Cox were ex-
cellent, the standard maze III procedure has met poor phy-
sician and patient acceptance due to its invasiveness
(sternotomy, CPB) and significant morbidity. Moreover, the
results achieved by Cox have not been reproduced by other
groups and many centers that adopted the maze procedure
did not achieve normal sinus rhythm conversion rates higher
than 70% to 80%.
Recent data suggest that an LA lesion pattern can
achieve results comparable to the maze III procedure al-
though extensive clinical data are needed.11-15 According to
Haissaguerre and colleagues16 and Chen and colleagues, 17
paroxysmal AF originates from focal ectopies arising from
the pulmonary veins and resulting in simultaneous reentrant
wavelets. Based on these findings and assuming that AF is
a disorder of the LA, the performance of a left-sided abla-
tion might be appropriate for treating paroxysmal and most
cases of chronic AF. Percutaneous methods may be applied
to the right atrium if needed. Consequently, innovative
approaches to AF ablation have been developed, consisting
of the confinement of the lesions to the LA, the substitution
of RF or other source of energy for atriotomies, and the
development of a closed heart epicardial off-pump ap-
proach.
Our objective was to develop an effective technique to
deliver the ablating energy from the epicardial surface be-
cause: (1) epicardial ablation might be safer as the energy is
directed into the atrial chamber rather than outward into
adjacent mediastinal structures; (2) CPB can be avoided; (3)
access to the relevant structures is easier than with catheter-
based techniques.
TABLE 2. Echocardiographic results
Variable Preablation Postablation P value
TMV (m/s) 2.34 0.32 2.64 0.3 .06
MR None None —
LVEF (%) 46.2 8.64 46.6 7.8 .9
WMA None None —
LA thrombus None None —
RPV diameter (mm) 0.54 0.09 0.52 0.08 .37
LPV diameter (mm) 0.7 0.12 0.74 0.19 .37
RPV flow
P1 (m/s) 0.94 0.09 0.98 0.08 .17
P2 (m/s) 0.86 0.09 0.84 0.13 .37
A (m/s) 0.34 0.11 0.32 0.08 .74
LPV flow
P1 (m/s) 1.22 0.21 1.38 0.26 .3
P2 (m/s) 1.02 0.04 1.04 0.06 .9
A (m/s) 0.36 0.13 0.38 0.13 .77
TMV, Peak transmitral valve inflow; MR, mitral regurgitation; LVEF, left
ventricular ejection fraction; WMA, wall motion abnormalities; LA, left
atrium; RPV, right pulmonary vein; LPV, left pulmonary vein.
Data are mean  SD; n  5.
Figure 4. Endocardial view of the posterior LA showing transmural lesions following TTC staining.
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The application of RF energy for atrial ablation may be
either unipolar or bipolar, irrigated or nonirrigated. In
unipolar RF, the energy is applied between the tip of the
electrode and a grounding plate.3,13,14 Bipolar RF energy
has recently been adopted in an experimental study to
achieve transmural lesions on the beating heart.18 We de-
veloped a bipolar device in which the energy is delivered
between 2 irrigated electrodes on the opposite jaws of a
clamping instrument. The bipolar mode was expected to
enhance the effectiveness of RF energy delivery to the
targeted atrial tissue while normal saline irrigation was
adopted to delay the impedance rise and produce deeper and
transmural lesions.19,20 The study conducted by Nakagawa
and colleagues19 showed that saline irrigation of RF elec-
trodes was associated with a reduction of the impedance at
the surface, allowing the energy to cross deeper into the
tissue and the surface cooling preventing any charring or
dessication. However, excellent transmurality results and no
charring were also achieved when bipolar energy was ap-
plied without irrigation and using a different lesion assess-
ment algorithm based on temperature control.18
A major concern when performing an epicardial ablation
is the accomplishment of transmural lesions to ensure con-
duction block. Transmurality may be impaired by the thick-
ness of the epicardium, which can be wrapped with fat
tissue, and the convective cooling of circulating blood. No
investigation comparing irrigated versus nonirrigated or im-
pedance versus temperature control has been published. In
this study, we demonstrated that beating heart epicardial LA
ablation was feasible and reproducible; the irrigated bipolar
RF device proved to be very effective in producing trans-
mural lesions and conduction block without signs of char-
ring or barotrauma. Moreover, the procedure could be per-
formed safely and under direct vision, avoiding any damage
to surrounding cardiac or mediastinal structures. The abla-
tion pattern that we adopted was described in a recent
experimental study by Kress and associates.11 It included a
bilateral pulmonary vein isolation that spared part of the
posterior LA wall, a connecting lesion between the 2 pul-
monary veins, the electrical isolation of the base of the
LAA, and a connecting lesion between the LPV and the
LAA lesions. The connecting lesion from the mitral valve to
the pulmonary veins was avoided because it may injure the
circumflex coronary artery and its utility is debatable.21,22
Our study shows that this pattern, which was highly suc-
cessful in a canine AF model,11 is feasible and safe when
performed epicardially and off-pump. The development of a
minimally invasive approach might further expand the in-
dications for lone AF surgical treatment.
Figure 5. Color-coded electrical mapping using the NOGAJ system: (A) preablation; (B) postablation. LAA, left
atrial appendage ablation; CL, connecting lesion; LPV, left pulmonary vein ablation; RPV, Right pulmonary vein
ablation.
TABLE 3. NOGA results
Variable Preablation Postablation P value
LA EDV (mL) 44 9.9 42.3 9 .42
LA ESV (mL) 34.55 8.9 34.25 6.8 .79
LA EF (%) 0.19 0.1 0.17 0.08 .47
Global LA AT (ms) 49.4 8.8 58.8 9 .18
Bipolar voltage  1 mV (%) 12.38 9 29.5 9.5 .01
LA, Left atrium; EDV, end-diastolic volume; ESV, end-systolic volume; EF,
ejection fraction; AT, activation time.
Data are mean  SD; n  5.
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The objective of surgical ablation is to restore normal
sinus rhythm, atrioventricular synchrony, and atrial contrac-
tion. It has been demonstrated that the atrial function is
depressed following electrical, pharmacological, and spon-
taneous cardioversion of AF.23,24 AF is associated with the
electrical, contractile, and structural remodeling of the atria
leading to reduced atrial function after cardioversion.25 Al-
though several studies have reported the presence of atrial
contractions after the maze procedure, little is known about
the atrial transport function. Some studies are consistent
with a decrease in the LA transport function after the maze
procedure in paroxysmal AF (ie, no associated heart dis-
ease).26,27 In addition to the effects of atrial remodeling,
further impairment of atrial function may be due to the
extensive cut and sew technique of the maze procedure,
which leads to atrial mass reduction, interruption of atrial
microcirculation, and tissue scarring.27-29
In this study we hypothesized that epicardial LA ablation
per se using a new bipolar RF device would not result in
significant electromechanical consequences upon normal
LA physiology. Intracardiac echocardiography and map-
ping using the NOGA system were used to assess the LA
electromechanical properties prior to and after ablation. We
found that although a significant amount of atrial myocar-
dium was either ablated or electrically isolated (ie, 17.12%
 9%), the global LA activation time and pattern, the LA
volumes and ejection fraction, the pulmonary vein diameter
and flows, and the TMV and LVEF were not significantly
altered. Moreover, no LA thrombus formation, mitral valve
regurgitation, or wall motion abnormality was detected
acutely following LA ablation.
Study Limitations
The experimental model is intended solely to study the
feasibility and safety of beating heart epicardial ablation
using a bipolar RF device. The electromechanical properties
were studied during normal sinus rhythm and therefore
reflect the effects of epicardial RF ablation per se upon LA
function and might not be applicable to the fibrillating LA.
The assessment was performed acutely (ie, 1 hour after
ablation) and further studies are warranted to exclude a
progressive decline of LA function and the development of
pulmonary vein stenosis in the longer term.
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